Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $1.76B.
ENTERPRISE VALUE (EV)
$1.76B
Mineralys Therapeutics, Inc.
Market Cap
$1.94B
Enterprise Value (EV)
$1.76B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Mineralys Therapeutics, Inc. (MLYS) | $1.94B | $1.76B |
| Establishment Labs Holdings Inc. (ESTA)vs › | $1.92B | $2.11B |
| AxoGen, Inc. (AXGN)vs › | $1.95B | $1.88B |
| Vir Biotechnology, Inc. (VIR)vs › | $1.96B | $1.77B |
| Inspire Medical Systems, Inc. (INSP)vs › | $1.97B | $1.87B |
| Fortrea Holdings Inc. (FTRE)vs › | $1.98B | $2.93B |
| Agios Pharmaceuticals, Inc. (AGIO)vs › | $1.89B | $1.83B |
| Zymeworks Inc. (ZYME)vs › | $1.89B | $1.98B |
| BioLife Solutions, Inc. (BLFS)vs › | $1.89B | $1.88B |
| Trevi Therapeutics, Inc. (TRVI)vs › | $1.87B | $1.82B |
Market Cap
$1.94B
Total Debt
$0.00
Cash
$172.92M
Enterprise Value
$1.76B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
